Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- Apr 04 2016
BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related...
- Mar 14 2016
BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related...
- Mar 09 2016
BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related...
- Mar 07 2016
BioLife Solutions, Inc. (NASDAQ: BLFS), a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related...
- Feb 25 2016Conference Call and Webcast at 4:30PM ET Today
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Feb 22 2016
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jan 27 2016
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Jan 25 2016CryoStor® Clinical Grade Cell Freeze Media Enabling Development of Novel Regenerative Medicine Therapies for Large Disease States
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Jan 07 2016Expanded Biopreservation Media Product Adoption, SaaS Cold Chain App Deployment, Planned Entry into Organ Preservation Solutions Market Set Stage for 2016 Growth
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Jan 06 2016evo Smart Shippers Could be Used to Transport a Variety of Temperature Sensitive Products for Research in Areas such as Cellular Therapies, Blood Cancers, and Solid Tumors
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Nov 23 2015Clinical Grade CryoStor® Cryopreservation Media Used to Freeze and Administer Cells to Patients in DYNAMIC Clinical Trial
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Nov 16 2015
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Nov 12 2015Conference Call and Webcast at 4:30PM EST Today
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Nov 02 2015
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Oct 22 2015Harvested Allogeneic Mesenchymal Bone Marrow Cells (aMBMC) Are Cryopreserved in CryoStor
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Oct 19 2015ATIR101™ Offers Potential Curative Stem Cell Transplant Option for the 35% of Eligible Cancer Patients Who Do Not Find a Matching Donor in Time
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Oct 05 201533% Biopreservation Media Revenue Growth over Q3 2014
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Sep 28 2015
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Sep 17 2015evo Smart Shippers Will Transport Leukopak Starting Material for CAR-T Cellular Immunotherapies Currently in 3rd Party Clinical Trials for Blood Cancers and Solid Tumors
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Sep 14 2015Novel T Cell Based Immunotherapy to be Evaluated in Melanoma, Kidney, and Lung Cancer in Groundbreaking Clinical Trial Design
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Aug 31 2015HypoThermosol® Cell Storage/Shipping Media to be Used in Commercial Manufacturing of Allogeneic Expanded Stem Cells for Complex Perianal Fistula in Crohn's Disease Patients
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Aug 06 2015Conference Call and Webcast at 4:30PM EDT Today
BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a...
- Jul 29 2015
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal...
- Jul 15 2015Over 2 Million Fresh Platelet Doses Administered Annually in the US Alone; Significant Growth Opportunity to Supply GMP Freeze Media for Cryopreserved Platelets
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and...
- Jul 13 2015Proprietary Biopreservation Media Products CryoStor® and HypoThermosol® Now Embedded in Nearly 200 Clinical Evaluations of New Cellular Therapeutics
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and...